NO20044346L - Fremgangsmåte for å behandle diabetes mellitus inkludert tilstander forbundet med diabetes mellitus og komplikasjoner ved diabetes mellitus - Google Patents

Fremgangsmåte for å behandle diabetes mellitus inkludert tilstander forbundet med diabetes mellitus og komplikasjoner ved diabetes mellitus

Info

Publication number
NO20044346L
NO20044346L NO20044346A NO20044346A NO20044346L NO 20044346 L NO20044346 L NO 20044346L NO 20044346 A NO20044346 A NO 20044346A NO 20044346 A NO20044346 A NO 20044346A NO 20044346 L NO20044346 L NO 20044346L
Authority
NO
Norway
Prior art keywords
diabetes mellitus
complications
procedures
conditions associated
including conditions
Prior art date
Application number
NO20044346A
Other languages
English (en)
Norwegian (no)
Inventor
P Haydn Pritchard
Tatjana Lukic
Kishor M Wasan
Original Assignee
Forbes Medi Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Forbes Medi Tech Inc filed Critical Forbes Medi Tech Inc
Publication of NO20044346L publication Critical patent/NO20044346L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20044346A 2002-03-14 2004-10-13 Fremgangsmåte for å behandle diabetes mellitus inkludert tilstander forbundet med diabetes mellitus og komplikasjoner ved diabetes mellitus NO20044346L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9874502A 2002-03-14 2002-03-14
PCT/CA2003/000369 WO2003075931A1 (fr) 2002-03-14 2003-03-14 Methode de traitement du diabete sucre, y compris les etats associes au diabete sucre et les complications du diabete sucre

Publications (1)

Publication Number Publication Date
NO20044346L true NO20044346L (no) 2004-12-09

Family

ID=27804294

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20044346A NO20044346L (no) 2002-03-14 2004-10-13 Fremgangsmåte for å behandle diabetes mellitus inkludert tilstander forbundet med diabetes mellitus og komplikasjoner ved diabetes mellitus

Country Status (11)

Country Link
EP (1) EP1482950A1 (fr)
JP (1) JP2005528353A (fr)
KR (1) KR20040104513A (fr)
CN (1) CN1681514A (fr)
AU (1) AU2003218547B2 (fr)
BR (1) BR0308396A (fr)
CA (1) CA2478931A1 (fr)
NO (1) NO20044346L (fr)
NZ (1) NZ535200A (fr)
RU (1) RU2334518C2 (fr)
WO (1) WO2003075931A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0329667D0 (en) 2003-12-22 2004-01-28 King S College London Core 2 GlcNAc-T inhibitor
GB0513881D0 (en) 2005-07-06 2005-08-10 Btg Int Ltd Core 2 GLCNAC-T Inhibitors III
US20080182801A1 (en) 2003-12-22 2008-07-31 Btg International Limited Core 2 glcnac-t inhibitors
GB0513888D0 (en) 2005-07-06 2005-08-10 Btg Int Ltd Core 2 GLCNAC-T Inhibitors II
GB0513883D0 (en) 2005-07-06 2005-08-10 Btg Int Ltd Diagnosis of Atherosclerosis
US7678399B2 (en) * 2005-12-05 2010-03-16 Bunge Oils, Inc. Phytosterol containing deep-fried foods and methods with health promoting characteristics
RU2547990C2 (ru) * 2009-09-28 2015-04-10 Интарсия Терапьютикс, Инк. Быстрое достижение и/или прекращение существенной стабильной доставки лекарственного средства
CA2997231A1 (fr) * 2015-09-03 2017-03-09 Natural Shield Israel 2016 Ltd Compositions combinees pour reguler des niveaux de glycemie, l'hepatoprotection, et pour la prevention et le traitement d'etats medicaux associes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2464465T3 (es) * 1994-09-29 2014-06-02 Pharmachem Laboratories, Inc. Composiciones de esteroles a partir de jabón de pulpa
EP1189924B1 (fr) * 1999-06-23 2004-08-18 Forbes Medi-Tech Inc. Conjugues de phytosterol ou de phytostanol et d'acide ascorbique, et leurs utilisations dans le traitement ou la prevention des maladies cardio-vasculaires

Also Published As

Publication number Publication date
NZ535200A (en) 2007-07-27
RU2004130463A (ru) 2005-04-10
CN1681514A (zh) 2005-10-12
CA2478931A1 (fr) 2003-09-18
RU2334518C2 (ru) 2008-09-27
BR0308396A (pt) 2005-01-11
KR20040104513A (ko) 2004-12-10
JP2005528353A (ja) 2005-09-22
AU2003218547B2 (en) 2007-11-01
EP1482950A1 (fr) 2004-12-08
WO2003075931A1 (fr) 2003-09-18
AU2003218547A1 (en) 2003-09-22

Similar Documents

Publication Publication Date Title
IL175949A0 (en) Benzenesulfonylamino-pyridin-2-yl derivatives and related compounds as inhibitors of 11-beta-hydroxy steroid dehydrogenase type1 (11-beta-hsd-1) for the treatment of diabetes and obesity
ZA200700904B (en) Method of treating sjögren's syndrome
IL218909A0 (en) Treatment of diabetes
SI1711184T1 (sl) (3-okso-3,4-dihidro-kinoksalin-2-il-amino)-benzamidni derivati in sorodne spojine kot inhibitorji glikogen-fosforilaze za zdravljenje diabetesa in debelosti
NO20035611D0 (no) Sammensetning og fremgangsmåte for kontroll ved behandling av hydrokarbon
PL366619A1 (en) Novel, arylsusfonamide compounds for the treatment of obesity, type ii diabetes and cns-disorders
IL153529A0 (en) Combinations of dipeptidyl peptidase iv inhibitors and other antidiabetic agents for the treatment of diabetes mellitus
EP1551399A4 (fr) Methode de traitement topique de maladies de l'oeil, composition et dispositif pour ce traitement
IL176259A0 (en) Compositions and methods for treating diabetes
AU2003279442A8 (en) 2-thiohydantoine derivative compounds and use thereof for the treatment of diabetes
AU2003236521A8 (en) Methods of reducing hypoglycemic episodes in the treatment of diabetes mellitus
PL377164A1 (pl) Pochodne anilinopirazolu przydatne do leczenia cukrzycy
IL177232A0 (en) Heteroarylaminopyrazole derivatives useful for the treatment of diabetes
ZA200409331B (en) Method of treating diabetes
NO20044346L (no) Fremgangsmåte for å behandle diabetes mellitus inkludert tilstander forbundet med diabetes mellitus og komplikasjoner ved diabetes mellitus
EP1774029A4 (fr) Procede pour detecter les risques de diabete non insulino-dependant et pour traiter ce type de diabete
NO20042012L (no) Sammensetning og fremgangsmate for behandling av diabetes
IL188787A0 (en) Prevention and treatment of ophthalmic complications of diabetes
NO20042389L (no) Anvendelse av en forbindelse ved behandling av sovnforstyrrelser og lignende ved a skaffe til veie utvilthet ved oppvakning og en fremgangsmate for behandling av omtakethet som er forbundet med dette
EP1909809A4 (fr) Methode et compositions permettant de traiter le diabete et ses complications
AU2003219421A1 (en) Treatment of diabetes and diabetic complications with nhe-1 inhibitors
EP1750698A4 (fr) Dérivés de 5-anilino-4-hétéroarylpyrazole utiles pour le traitement du diabete
DK1598350T3 (da) Pyrrolidin- og thiazolidinforbindelser, fremgangsmåde til fremstilling heraf og deres anvendelse til behandling af hypoglykæmi og diabetes II
HUP0300990D0 (en) Synergistic combination for the prophylaxis and treatment of diabetes
AU2003283938A1 (en) Use of certain compounds in treatment of obesity